4-carboxyfluorescein has been researched along with maytansine in 1 studies
| Studies (4-carboxyfluorescein) | Trials (4-carboxyfluorescein) | Recent Studies (post-2010) (4-carboxyfluorescein) | Studies (maytansine) | Trials (maytansine) | Recent Studies (post-2010) (maytansine) |
|---|---|---|---|---|---|
| 116 | 0 | 53 | 815 | 96 | 592 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higuchi, K; Inoue, K; Kishimoto, H; Miyasato, M; Sato, T; Shirasaka, Y; Takada, T; Tomabechi, R | 1 |
1 other study(ies) available for 4-carboxyfluorescein and maytansine
| Article | Year |
|---|---|
Identification of 5-Carboxyfluorescein as a Probe Substrate of SLC46A3 and Its Application in a Fluorescence-Based In Vitro Assay Evaluating the Interaction with SLC46A3.
Topics: Ado-Trastuzumab Emtansine; Breast Neoplasms; Female; Fluorescence; Humans; Immunoconjugates; Maytansine; Receptor, ErbB-2; Trastuzumab | 2023 |